99 related articles for article (PubMed ID: 11493991)
1. Allelic Deletion of VHL Gene Detected in Papillary Tumors of the Broad Ligament, Epididymis, and Retroperitoneum in von Hippel-Lindau Disease Patients.
Shen T; Zhuang Z; Gersell DJ; Tavassoli FA
Int J Surg Pathol; 2000 Jul; 8(3):207-212. PubMed ID: 11493991
[TBL] [Abstract][Full Text] [Related]
2. Somatic von Hippel-Lindau mutation in clear cell papillary cystadenoma of the epididymis.
Gilcrease MZ; Schmidt L; Zbar B; Truong L; Rutledge M; Wheeler TM
Hum Pathol; 1995 Dec; 26(12):1341-6. PubMed ID: 8522307
[TBL] [Abstract][Full Text] [Related]
3. Papillary cystadenoma of the epididymis and broad ligament: morphologic and immunohistochemical overlap with clear cell papillary renal cell carcinoma.
Cox R; Vang R; Epstein JI
Am J Surg Pathol; 2014 May; 38(5):713-8. PubMed ID: 24441657
[TBL] [Abstract][Full Text] [Related]
4. A detailed immunohistochemical analysis of 2 cases of papillary cystadenoma of the broad ligament: an extremely rare neoplasm characteristic of patients with von hippel-lindau disease.
Brady A; Nayar A; Cross P; Patel A; Naik R; Lee S; Kaushik S; Barton D; McCluggage WG
Int J Gynecol Pathol; 2012 Mar; 31(2):133-40. PubMed ID: 22317868
[TBL] [Abstract][Full Text] [Related]
5. Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas.
Vortmeyer AO; Lubensky IA; Fogt F; Linehan WM; Khettry U; Zhuang Z
Am J Pathol; 1997 Oct; 151(4):951-6. PubMed ID: 9327728
[TBL] [Abstract][Full Text] [Related]
6. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
Lubensky IA; Gnarra JR; Bertheau P; Walther MM; Linehan WM; Zhuang Z
Am J Pathol; 1996 Dec; 149(6):2089-94. PubMed ID: 8952541
[TBL] [Abstract][Full Text] [Related]
7. Aggressive papillary tumor of middle ear/temporal bone and adnexal papillary cystadenoma. Manifestations of von Hippel-Lindau disease.
Gaffey MJ; Mills SE; Boyd JC
Am J Surg Pathol; 1994 Dec; 18(12):1254-60. PubMed ID: 7977949
[TBL] [Abstract][Full Text] [Related]
8. Bilateral papillary cystadenoma of the mesosalpinx: a rare manifestation of Von Hippel-Lindau disease.
Zanotelli DB; Bruder E; Wight E; Troeger C
Arch Gynecol Obstet; 2010 Sep; 282(3):343-6. PubMed ID: 20157715
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas.
Lee JY; Dong SM; Park WS; Yoo NJ; Kim CS; Jang JJ; Chi JG; Zbar B; Lubensky IA; Linehan WM; Vortmeyer AO; Zhuang Z
Cancer Res; 1998 Feb; 58(3):504-8. PubMed ID: 9458097
[TBL] [Abstract][Full Text] [Related]
10. Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis.
Lubensky IA; Pack S; Ault D; Vortmeyer AO; Libutti SK; Choyke PL; Walther MM; Linehan WM; Zhuang Z
Am J Pathol; 1998 Jul; 153(1):223-31. PubMed ID: 9665483
[TBL] [Abstract][Full Text] [Related]
11. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
Jensen RL; Gillespie D; House P; Layfield L; Shelton C
J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
[TBL] [Abstract][Full Text] [Related]
12. Germline mutation of von Hippel-Lindau (VHL) gene 695 G>A (R161Q) in a patient with a peculiar phenotype with type 2C VHL syndrome.
Santarpia L; Lapa D; Benvenga S
Ann N Y Acad Sci; 2006 Aug; 1073():198-202. PubMed ID: 17102087
[TBL] [Abstract][Full Text] [Related]
13. Von Hippel-Lindau disease.
Sano T; Horiguchi H
Microsc Res Tech; 2003 Feb; 60(2):159-64. PubMed ID: 12539169
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
[TBL] [Abstract][Full Text] [Related]
15. Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma.
Koch CA; Huang SC; Zhuang Z; Stolle C; Azumi N; Chrousos GP; Vortmeyer AO; Pacak K
Oncogene; 2002 Jan; 21(3):479-82. PubMed ID: 11821960
[TBL] [Abstract][Full Text] [Related]
16. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of magnetic resonance imaging findings in pancreatic and other abdominal manifestations of Von Hippel-Lindau disease in a series of 23 patients: a pictorial review.
Graziani R; Mautone S; Vigo M; Manfredi R; Opocher G; Falconi M
JOP; 2014 Jan; 15(1):1-18. PubMed ID: 24413778
[TBL] [Abstract][Full Text] [Related]
18. Somatic point mutation of the wild-type allele detected in tumors of patients with VHL germline deletion.
Vortmeyer AO; Huang SC; Pack SD; Koch CA; Lubensky IA; Oldfield EH; Zhuang Z
Oncogene; 2002 Feb; 21(8):1167-70. PubMed ID: 11850836
[TBL] [Abstract][Full Text] [Related]
19. Frequent allelic loss at chromosome arm 3p is distinct from genetic alterations of the Von-Hippel Lindau tumor suppressor gene in head and neck cancer.
Waber PG; Lee NK; Nisen PD
Oncogene; 1996 Jan; 12(2):365-9. PubMed ID: 8570213
[TBL] [Abstract][Full Text] [Related]
20. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas.
Dannenberg H; De Krijger RR; van der Harst E; Abbou M; IJzendoorn Y; Komminoth P; Dinjens WN
Int J Cancer; 2003 Jun; 105(2):190-5. PubMed ID: 12673678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]